Optimization of Crospovidone and Copovidone in Fast Disintegrating Tablet (FDT) Diphenhydramine HCl Using Factorial Design

Agatha Budi Susiana Lestari; Aldo Christian Jonathan

doi:10.24071/jpsc.006396

Optimization of Crospovidone and Copovidone in Fast Disintegrating Tablet (FDT) Diphenhydramine HCl Using Factorial Design

Agatha Budi Susiana Lestari^(1*), Aldo Christian Jonathan⁽²⁾,

(1) Faculty of Pharmacy, Universitas Sanata Dharma
(2) Faculty of Pharmacy, Universitas Sanata Dharma
(*) Corresponding Author

Abstract

Diphenhydramine HCl is a drug used to treat motion sickness. Treatment of motion sickness needs rapid onset for successful therapy. Fast Disintegrating Tablet (FDT) is one dosage form that provides fast onset. The purpose of this study was to identify the dominant factors of crospovidone and copovidone, their interactions, and discover the optimum composition area to produce a FDT dosage form with optimum parameters involving hardness, friability, disintegration time, wetting time, and water absorption ratio. This study was experimental and used a factorial design. The result showed that copovidone significantly influenced friability, disintegration time, wetting time, and water absorption ratio, while their interactions significantly influenced the hardness of FDT diphenhydramine HCl. At the level studied, the optimum composition area was found, which can be predicted as a diphenhydramine HCl FDT dosage form formula.

Keywords

Copovidone; Crospovidone; Diphenhydramine HCl; Factorial design; Fast disintegrating tablet;

Full Text:

PDF

References

AOAC International, 2016. Guidelines for Standard Method Performance Requirements. AOAC Official Methods of Analysis.

British Pharmacopoeia Commission, 2011. British Pharmacopoeia 2011. London: TSO.

Chacko, A.J., Jose, S., Babu, N., Michelle, M., Jose, S., 2010. Design and Development of Orodispersible Tablets of Promethazine Theoclate Using Coprocessed Superdisintegrants and Subliming Materials. Int. J. Innov. Pharm. Res., 1(2), 53–56.

Chime, S.A., Brown, S.A., Ugwu, C.E., Agubata, C.O., Obidike, T.C., Onunkwo, G.C., 2012. Effect of Binder Type and Concentration on The In Vitro Properties of Alstonia Boonei Tablets, Int. J. Pharm. Sci. Rev. Res., 16(2), 5–9.

Deshmukh, V.N., Zade, N.H., Sakarkar, D.M., 2012. Development and evaluation of orally disintegrating tablet by direct compression method. International Journal of PharmTech Research, 4 (4), 1351–1357.

Fatohy, H. and Abdul-rasool, A. a, 2013. Effect of Different Diluent and Binder Types on the Preparation of Bisoprolol Fumarate as Tablet Dosage Form. Iraqi J Pharm Science, 22 (1), 32–39.

Food and Drug Administration, 2008. Guidance for Industry: Orally Disintegrating Tablets. Center for Drug Evaluation and Research (CDER).

Food and Drug Administration, 2014. APPENDIX 1 – ORA Validation and Verification Guidance for Human Drug Analytical Methods. Food and Drug Administration.

Gowtham, M., Muhammed Sharis, C., Moidu, M., Meharunneesa, K., Anaz, M., Paridhavi, M., 2011. Formulation and Evaluation of Fast Dissolving Diphenhydramine Hydrochloride Tablets. International Journal of Drug Formulation and Research, 02(05), 309–319.

Jyothi, A.A., Mounika, P., Vineesha, S., Mehdia, S., Dutt, A.N., 2013. Formulatiom Development and Evaluation of Oral Thin Films- Diphenhydramine HCl. International Journal of Pharmaceutical Sciences and Research, 4(9), 3484–3488.

Katzung, B.G., Masters, S.B., Trevor, A.J., 2012. Histamine, Serotonin & The Ergots Alkaloids. In: Basic & Clinical Pharmacology. Lange Medical Publications, 278.

Ministry of Health of the Republic of Indonesia, 2020. Indonesian Pharmacopeia VI. Jakarta: Ministry of Health of the Republic of Indonesia.

Mishra, A.K., Kumar, A., Mishra, A., 2010. Development and Validation of UV Spectrophotometric Method for Estimation of Diphenhydramine Hydrochloride in Soft Gelatin Capsule. International Journal of Pharmaceutical Sciences and Research, 1(8), 144–148.

Mohanachandran, P.S., Sindhumol, P.G., Kiran, T.S., 2011. Superdisintegrants: An overview. Int. J. Pharm. Sci. Rev. Res., 6(1), 105–109.

Moroni, A., 2001. A novel copovidone binder for dry granulation and direct-compression tableting. Pharmaceutical Technology DRUG DELIVERY, 25(9), 8–13.

Pabari, R.M. and Ramtoola, Z., 2012. Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets. Journal of Young Pharmacists, 4 (3), 157–163.

Qiu, Y., Chen, Y., Zhang, G.G.Z., Yu, L., Mantri, R. V., 2017. Developing Solid Oral Dosage Forms Pharmaceutical Theory & Practice. 2nd ed. Mica Haley.

Satpute, M.M. and Tour, N.S., 2013. Formulation and In Vitro Evaluation of Fast Dissolving Tablets of Metoprolol Tartrate. Brazilian Journal of Pharmaceutical Sciences, 49(4), 783–792.

Sharma, D., Singh, G., Kumar, D., Singh, M., 2015. Formulation Development and Evaluation of Fast Disintegrating Tablets of Salbutamol Sulphate, Cetirizine Hydrochloride in Combined Pharmaceutical Dosage Form: A New Era In Novel Drug Delivery For Pediatrics And Geriatrics. Journal of Drug Delivery, 2015, 640529.

Whelan, R. and Apfel, C.C., 2013. Pharmacology of Postoperative Nausea and Vomiting. In: Pharmacology and Physiology for Anesthesia. Philadelphia: Elsevier Inc., 503–522.

DOI: https://doi.org/10.24071/jpsc.006396